YAP/TAZ inactivation with simvastatin attenuates glucocorticoid-induced human trabecular meshwork cell dysfunction
H. Yoo, A. Singh, H. Li, A. N. Strat, T. Bague, P. S. Ganapathy, S. Herberg
This study shows that simvastatin reduces YAP/TAZ activity and ECM dysfunction in glucocorticoid-treated human trabecular meshwork cells.
bioRxiv · Sep 27, 2022 · PreprintCell Biology